Psylo is a drug development company focused on next generation psychedelics; Their goal is to make broadly accessible medicines as improved treatments to currently available SSRI medications, using psychedelic molecules as the starting point. They are building a pipeline of novel molecules with the ultimate goal of taking leading candidates through to clinical trials.